TMOD1

Chr 9

tropomodulin 1

Also known as: D9S57E, ETMOD, TMOD

The protein caps the pointed ends of actin filaments by binding to tropomyosin's N-terminus, blocking filament elongation and depolymerization to regulate erythrocyte membrane skeleton structure. Gain-of-function mutations cause congenital myopathy with nemaline rods through disruption of skeletal muscle actin filament organization. The condition follows an autosomal dominant inheritance pattern.

OMIMResearchSummary from RefSeq, UniProt, Mechanism
MultiplemechanismLOEUF 0.48
Clinical SummaryTMOD1
🧬
Gene-Disease Validity (ClinGen)
dilated cardiomyopathy · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.21) despite low pLI — interpret in context.
📋
ClinVar Variants
32 unique Pathogenic / Likely Pathogenic· 49 VUS of 92 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.48LOEUF
pLI 0.478
Z-score 3.18
OE 0.21 (0.100.48)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.23Z-score
OE missense 0.76 (0.670.87)
160 obs / 210.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.21 (0.100.48)
00.351.4
Missense OE0.76 (0.670.87)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 4 / 19.0Missense obs/exp: 160 / 210.1Syn Z: -0.44
DN
0.6649th %ile
GOF
0.6931th %ile
LOF
0.3647th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

92 submitted variants in ClinVar

Classification Summary

Pathogenic28
Likely Pathogenic4
VUS49
Likely Benign2
28
Pathogenic
4
Likely Pathogenic
49
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
28
0
28
Likely Pathogenic
0
0
4
0
4
VUS
0
45
4
0
49
Likely Benign
0
0
1
1
2
Benign
0
0
0
0
0
Total04537183

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TMOD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →